Literature DB >> 26783045

TNFA, ANXA11 and BTNL2 Polymorphisms in CVID Patients with Granulomatous Disease.

David Boutboul1,2, Nicolas Vince1, Matthieu Mahevas3, Jean-Christophe Bories1, Claire Fieschi4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26783045     DOI： 10.1007/s10875-016-0234-0

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  7 in total

1.  TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease.

Authors:  C G Mullighan; G C Fanning; H M Chapel; K I Welsh
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

2.  Sarcoidosis is associated with a truncating splice site mutation in BTNL2.

Authors:  Ruta Valentonyte; Jochen Hampe; Klaus Huse; Philip Rosenstiel; Mario Albrecht; Annette Stenzel; Marion Nagy; Karoline I Gaede; Andre Franke; Robert Haesler; Andreas Koch; Thomas Lengauer; Dirk Seegert; Norbert Reiling; Stefan Ehlers; Eberhard Schwinger; Matthias Platzer; Michael Krawczak; Joachim Müller-Quernheim; Manfred Schürmann; Stefan Schreiber
Journal:  Nat Genet       Date:  2005-02-27       Impact factor: 38.330

3.  Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis.

Authors:  Diane Bouvry; Luc Mouthon; Pierre-Yves Brillet; Marianne Kambouchner; Jean-Pierre Ducroix; Vincent Cottin; Julien Haroche; Jean-Francois Viallard; Romain Lazor; François Lebargy; Abdellatif Tazi; Benoît Wallaert; Amar Smail; Jean-Luc Pellegrin; Hilario Nunes; Zahir Amoura; Jean-François Cordier; Dominique Valeyre; Jean-Marc Naccache
Journal:  Eur Respir J       Date:  2012-08-16       Impact factor: 16.671

Review 4.  Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients.

Authors:  Jean-Nicolas Boursiquot; Laurence Gérard; Marion Malphettes; Claire Fieschi; Lionel Galicier; David Boutboul; Raphael Borie; Jean-François Viallard; Pauline Soulas-Sprauel; Alice Berezne; Arnaud Jaccard; Eric Hachulla; Julien Haroche; Nicolas Schleinitz; Laurent Têtu; Eric Oksenhendler
Journal:  J Clin Immunol       Date:  2012-09-18       Impact factor: 8.317

5.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

Authors:  Helen Chapel; Mary Lucas; Martin Lee; Janne Bjorkander; David Webster; Bodo Grimbacher; Claire Fieschi; Vojtech Thon; Mohammad R Abedi; Lennart Hammarstrom
Journal:  Blood       Date:  2008-03-04       Impact factor: 22.113

6.  Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis.

Authors:  Sylvia Hofmann; Andre Franke; Annegret Fischer; Gunnar Jacobs; Michael Nothnagel; Karoline I Gaede; Manfred Schürmann; Joachim Müller-Quernheim; Michael Krawczak; Philip Rosenstiel; Stefan Schreiber
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

7.  The immune paradox of sarcoidosis and regulatory T cells.

Authors:  Makoto Miyara; Zahir Amoura; Christophe Parizot; Cécile Badoual; Karim Dorgham; Salim Trad; Marianne Kambouchner; Dominique Valeyre; Catherine Chapelon-Abric; Patrice Debré; Jean-Charles Piette; Guy Gorochov
Journal:  J Exp Med       Date:  2006-01-23       Impact factor: 14.307
  7 in total
  3 in total

Review 1.  Annexin Animal Models-From Fundamental Principles to Translational Research.

Authors:  Thomas Grewal; Carles Rentero; Carlos Enrich; Mohamed Wahba; Carsten A Raabe; Ursula Rescher
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

2.  The BTNL2 G16071A gene polymorphism increases granulomatous disease susceptibility: A meta-analysis including FPRP test of 8710 participants.

Authors:  Xiang Tong; Yao Ma; Xundong Niu; Zhipeng Yan; Sitong Liu; Bo Peng; Shifeng Peng; Hong Fan
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

3.  A Temporal Comparative RNA Transcriptome Profile of the Annexin Gene Family in the Salivary versus Lacrimal Glands of the Sjögren's Syndrome-Susceptible C57BL/6.NOD-Aec1Aec2 Mouse.

Authors:  Ammon B Peck; Julian L Ambrus
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.